Sari Feld

1.2k total citations
23 papers, 1.0k citations indexed

About

Sari Feld is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Sari Feld has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Cell Biology and 7 papers in Immunology. Recurrent topics in Sari Feld's work include Proteoglycans and glycosaminoglycans research (13 papers), Glycosylation and Glycoproteins Research (8 papers) and Fibroblast Growth Factor Research (7 papers). Sari Feld is often cited by papers focused on Proteoglycans and glycosaminoglycans research (13 papers), Glycosylation and Glycoproteins Research (8 papers) and Fibroblast Growth Factor Research (7 papers). Sari Feld collaborates with scholars based in Israel, Sweden and United States. Sari Feld's co-authors include Israël Vlodavsky, Neta Ilan, Vladislav Temkin, Francesca Levi‐Schaffer, Inna Naroditsky, Flonia Levy‐Adam, Gil Arvatz, Maria Paola Landini, Giada Frascaroli and Stefania Varani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Sari Feld

23 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sari Feld Israel 15 491 490 324 128 114 23 1.0k
Gil Arvatz Israel 11 453 0.9× 513 1.0× 66 0.2× 112 0.9× 77 0.7× 14 752
Sibylla Martinelli Switzerland 7 93 0.2× 228 0.5× 381 1.2× 70 0.5× 59 0.5× 7 642
Yuzo Kodaira Japan 6 114 0.2× 169 0.3× 444 1.4× 98 0.8× 53 0.5× 10 685
Michael Plotnick United States 14 87 0.2× 234 0.5× 204 0.6× 67 0.5× 60 0.5× 15 715
William K. Hart United States 4 94 0.2× 419 0.9× 335 1.0× 74 0.6× 88 0.8× 7 995
Carola Sjölin Sweden 12 135 0.3× 265 0.5× 275 0.8× 51 0.4× 142 1.2× 15 680
Fiona C. Kimberley Netherlands 11 66 0.1× 583 1.2× 464 1.4× 67 0.5× 34 0.3× 13 924
Andreas Kerstan Germany 20 60 0.1× 406 0.8× 550 1.7× 128 1.0× 107 0.9× 59 1.3k
Rachel Golub France 24 233 0.5× 373 0.8× 1.3k 3.9× 68 0.5× 82 0.7× 52 1.7k
Christopher A. Lundquist United States 8 129 0.3× 740 1.5× 174 0.5× 182 1.4× 15 0.1× 9 1.3k

Countries citing papers authored by Sari Feld

Since Specialization
Citations

This map shows the geographic impact of Sari Feld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sari Feld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sari Feld more than expected).

Fields of papers citing papers by Sari Feld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sari Feld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sari Feld. The network helps show where Sari Feld may publish in the future.

Co-authorship network of co-authors of Sari Feld

This figure shows the co-authorship network connecting the top 25 collaborators of Sari Feld. A scholar is included among the top collaborators of Sari Feld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sari Feld. Sari Feld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naroditsky, Inna, Sari Feld, Ilanit Boyango, et al.. (2024). Nuclear localization of heparanase 2 (Hpa2) attenuates breast carcinoma growth and metastasis. Cell Death and Disease. 15(3). 232–232. 4 indexed citations
2.
Feld, Sari, et al.. (2021). Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2. Frontiers in Oncology. 10. 627463–627463. 8 indexed citations
3.
Weissmann, Marina, Udayan Bhattacharya, Sari Feld, et al.. (2018). The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action. Matrix Biology. 77. 58–72. 41 indexed citations
4.
Katz, Amit, Uri Barash, Ilanit Boyango, et al.. (2018). Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer. Oncotarget. 9(27). 19294–19306. 9 indexed citations
5.
Singh, Preeti, Alexandra Blatt, Sari Feld, et al.. (2017). The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression. Neoplasia. 19(3). 175–184. 20 indexed citations
6.
Feld, Sari, Ilana Doweck, Gera Neufeld, et al.. (2016). Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth. Cancer Research. 76(9). 2791–2801. 35 indexed citations
7.
Weissmann, Marina, Gil Arvatz, Netanel A. Horowitz, et al.. (2016). Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis. Proceedings of the National Academy of Sciences. 113(3). 704–709. 89 indexed citations
8.
Vornicova, Olga, Ilanit Boyango, Sari Feld, et al.. (2016). The prognostic significance of heparanase expression in metastatic melanoma. Oncotarget. 7(46). 74678–74685. 25 indexed citations
9.
Barash, Uri, Gil Arvatz, Inna Naroditsky, et al.. (2012). Clinical Significance of Heparanase Splice Variant (T5) in Renal Cell Carcinoma: Evaluation by a Novel T5-Specific Monoclonal Antibody. PLoS ONE. 7(12). e51494–e51494. 10 indexed citations
10.
Levy‐Adam, Flonia, Sari Feld, Victoria Cohen‐Kaplan, et al.. (2010). Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase Activity. Journal of Biological Chemistry. 285(36). 28010–28019. 113 indexed citations
11.
Fux, Liat, Victoria Cohen‐Kaplan, Svetlana Gingis‐Velitski, et al.. (2009). Structure-Function Approach Identifies a COOH-Terminal Domain That Mediates Heparanase Signaling. Cancer Research. 69(5). 1758–1767. 84 indexed citations
12.
Levy‐Adam, Flonia, Sari Feld, Edith Suss-Toby, Israël Vlodavsky, & Neta Ilan. (2008). Heparanase Facilitates Cell Adhesion and Spreading by Clustering of Cell Surface Heparan Sulfate Proteoglycans. PLoS ONE. 3(6). e2319–e2319. 88 indexed citations
13.
Varani, Stefania, Sari Feld, Charlotte Tammik, et al.. (2007). Human Cytomegalovirus Differentially Controls B Cell and T Cell Responses through Effects on Plasmacytoid Dendritic Cells. The Journal of Immunology. 179(11). 7767–7776. 80 indexed citations
14.
Varani, Stefania, et al.. (2004). Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. Journal of Leukocyte Biology. 77(2). 219–228. 69 indexed citations
15.
Söderström, Ingegerd, et al.. (1999). Altered VH6-D-JH repertoire in human insulin-dependent diabetes mellitus and autoimmune idiopathic thrombocytopenic purpura. European Journal of Immunology. 29(9). 2853–2862. 2 indexed citations
16.
Feld, Sari, et al.. (1999). Increased Utilization of the VH6 Gene Family in Patients with Autoimmune Idiopathic Thrombocytopenic Purpura. Journal of Autoimmunity. 12(1). 57–63. 11 indexed citations
17.
Levi‐Schaffer, Francesca, et al.. (1998). Mast Cells Enhance Eosinophil Survival In Vitro: Role of TNF-α and Granulocyte-Macrophage Colony-Stimulating Factor. The Journal of Immunology. 160(11). 5554–5562. 84 indexed citations
18.
Söderström, Ingegerd, et al.. (1997). Age‐related impaired affinity maturation and differential D‐JH gene usage in human VH6‐expressing B lymphocytes from healthy individuals. European Journal of Immunology. 27(6). 1381–1386. 44 indexed citations
19.
Söderström, Ingegerd, Sari Feld, Corrado Cilio, et al.. (1997). Aberrant VHGene Utilization in Patients with Established Insulin-Dependent Diabetes Mellitus. Journal of Autoimmunity. 10(2). 157–163. 9 indexed citations
20.
Feld, Sari, et al.. (1989). Pernicious anemia, Hashimoto's thyroiditis and Sjögren's in a woman with SLE and autoimmune hemolytic anemia.. PubMed. 16(2). 258–9. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gil Arvatz Breakdown of academic impact, for papers by Sibylla Martinelli Breakdown of academic impact, for papers by Yuzo Kodaira Breakdown of academic impact, for papers by Michael Plotnick Breakdown of academic impact, for papers by William K. Hart Breakdown of academic impact, for papers by Carola Sjölin Breakdown of academic impact, for papers by Fiona C. Kimberley Breakdown of academic impact, for papers by Andreas Kerstan Breakdown of academic impact, for papers by Rachel Golub Breakdown of academic impact, for papers by Christopher A. Lundquist
Rankless by CCL
2026